Une transfusion « ponctuelle » ne modifie pas l’interprétation des dosages biologiques utiles à la compréhension de l’étiologie d’une anémie. Résultats d’une étude prospective : l’étude BÉA/T
Antoine Froissart(Hôpital Beaujon), B. Fantin(Délégation Paris 5), Inmaculada Jarrín(Instituto de Salud Carlos III), S. Dautheville(Sorbonne Université), Nathalie Gault(Inserm), Olivier Steichen(Inserm), Brigitte Ranque(Hôpital Européen), Jean‐François Bergmann(Northern General Hospital), Virginie Zarrouk(Université Paris Cité), Benjamín Rossi(Hôpital Beaujon), C. Roy(Hôpital Beaujon)
Cited by 0
Related Papers
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19
|Journal of Infection|2020|1.2k
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
|The Lancet Infectious Diseases|2017|587
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Comparative Antibiotic Dose-Effect Relations at Several Dosing Intervals in Murine Pneumonitis and Thigh-Infection Models
|The Journal of Infectious Diseases|1989|353
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342